论文信息 - Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell–Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia - 字舞流文

Preclinical Characterization of AMG 330, a CD3/CD33-Bispecific T-Cell–Engaging Antibody with Potential for Treatment of Acute Myelogenous Leukemia

A. Henn | M. Friedrich | P. Hoffmann | R. Kischel | P. Kufer | T. Raum | B. Rattel | J. Wahl | P. Baeuerle | J. Slootstra | Majk Kvesic | Katja Matthes | Monika Bajtus | Larissa Hendrich | Tobias Raum